CSIMarket
 


Five Prime Therapeutics Inc   (FPRX)
Other Ticker:  
 
 

FPRX's Income from Cont. Operations Growth by Quarter and Year

Five Prime Therapeutics Inc 's Income from Cont. Operations results by quarter and year




FPRX Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December -20.85 -31.36 -29.53 -29.21
III Quarter September -26.42 -36.07 -47.24 -43.28
II Quarter June -16.94 -34.39 -34.06 -44.29
I Quarter March -20.12 -35.39 -20.39 -33.44
FY   -84.33 -137.21 -131.22 -150.22



FPRX Income from Cont. Operations fourth quarter 2020 Y/Y Growth Comment
Five Prime Therapeutics Inc in the fourth quarter 2020 recorded loss from continued operations of $ -20.85 millions.

According to the results reported in the fourth quarter 2020, Five Prime Therapeutics Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Five Prime Therapeutics Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the fourth quarter 2020.




FPRX Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Five Prime Therapeutics Inc 's fourth quarter 2020 Income from Cont. Operations $ -20.85 millions FPRX's Income Statement
Five Prime Therapeutics Inc 's fourth quarter 2019 Income from Cont. Operations $ -31.36 millions Quarterly FPRX's Income Statement
New: More FPRX's historic Income from Cont. Operations Growth >>


FPRX Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Five Prime Therapeutics Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FPRX's IV. Quarter Q/Q Income from Cont. Operations Comment
Despite the fact, that Five Prime Therapeutics Inc in the IV. Quarter 2020 admitted loss from continued operations of $ -20.85 millions, some analyst said, that those numbers are slight up side relative to the -26.42 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Five Prime Therapeutics Inc achieved highest sequential Income from Cont. Operations growth. While Five Prime Therapeutics Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FPRX's IV. Quarter Q/Q Income from Cont. Operations Comment
Despite the fact, that Five Prime Therapeutics Inc in the IV. Quarter 2020 admitted loss from continued operations of $ -20.85 millions, some analyst mentioned, that those numbers are slight up side compare to the -26.42 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Five Prime Therapeutics Inc achieved highest sequential Income from Cont. Operations growth. While Five Prime Therapeutics Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Five Prime Therapeutics Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
Cumulative Income from Cont. Operations 12 Months Ending $ -84.33 $ -94.83 $ -104.48 $ -121.93 $ -137.20
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment


Five Prime Therapeutics Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment


Five Prime Therapeutics Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
FPRX's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for FPRX's Competitors
Income from Cont. Operations Growth for Five Prime Therapeutics Inc 's Suppliers
Income from Cont. Operations Growth for FPRX's Customers

You may also want to know
FPRX's Annual Growth Rates FPRX's Profitability Ratios FPRX's Asset Turnover Ratio FPRX's Dividend Growth
FPRX's Roe FPRX's Valuation Ratios FPRX's Financial Strength Ratios FPRX's Dividend Payout Ratio
FPRX's Roa FPRX's Inventory Turnover Ratio FPRX's Growth Rates FPRX's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 31 2020
Fresenius Medical Care Ag-0.19%$ -0.185 millions
Sensus Healthcare Inc -1.99%$ -1.991 millions
Xeris Biopharma Holdings Inc -2.78%$ -2.784 millions
Dr Reddy s Laboratories Limited-4.78%$ -4.779 millions
Amgen Inc -5.17%$ -5.167 millions
National Research Corporation-5.59%$ -5.587 millions
Fonar Corporation-6.68%$ -6.676 millions
Zoetis Inc -6.77%$ -6.771 millions
Supernus Pharmaceuticals inc -7.13%$ -7.127 millions
Abiomed Inc -10.62%$ -10.617 millions
Lifevantage Corp-11.41%$ -11.411 millions
Icon Plc-11.41%$ -11.412 millions
Corcept Therapeutics Inc-11.53%$ -11.528 millions
Taro Pharmaceutical Industries Ltd-13.32%$ -13.318 millions
Radnet Inc -13.37%$ -13.369 millions
Davita Inc -15.43%$ -15.426 millions
Carlisle Companies Incorporated-18.56%$ -18.558 millions
Stryker Corp-21.66%$ -21.655 millions
Utah Medical Products Inc-21.71%$ -21.707 millions
Kamada Ltd -22.97%$ -22.970 millions
Enovis Corporation-27.71%$ -27.713 millions
Ufp Technologies Inc -27.78%$ -27.783 millions
Teleflex Incorporated-28.93%$ -28.934 millions
Amarin Corp Plcuk-30.31%$ -30.306 millions
Novartis Ag-31.23%$ -31.235 millions
Pra Health Sciences Inc -31.48%$ -31.476 millions
Springworks Therapeutics Inc -33.04%$ -33.036 millions
Pacific Health Care Organization Inc -35.40%$ -35.397 millions
Concert Pharmaceuticals Inc -37.70%$ -37.699 millions
Zynex inc -39.36%$ -39.362 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com